<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00421330</url>
  </required_header>
  <id_info>
    <org_study_id>00/144</org_study_id>
    <nct_id>NCT00421330</nct_id>
  </id_info>
  <brief_title>Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial</brief_title>
  <official_title>Endovascular Versus Transabdominal Treatment of the Abdominal Aortic Aneurysm: the Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to assess whether the new endovascular repair technique of the
      abdominal aortic aneurysm (AAA) is an adequate substitute of the conventional AAA repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After the introduction of endovascular repair of abdominal aortic aneurysms (AAA), both
      benefits and drawbacks of this new technique have been reported. To assess whether the new
      technique is an adequate substitute of conventional AAA repair, a randomised study is
      required. The DREAM trial is a randomised multicenter trial enrolling patients eligible for
      elective treatment of infrarenal AAAs. The primary endpoint is combined operative mortality
      and morbidity. Secondary endpoints and additional assessments include event-free survival,
      quality of life,and costs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2000</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>combined operative mortality and morbidity</measure>
    <time_frame>5-8 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>event free survival</measure>
    <time_frame>5-8 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>5-8 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost-effectiveness</measure>
    <time_frame>5-8 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">392</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>OR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open Aneurysm Repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EVAR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endovascular Aneurysm Repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Aneurysm Repair</intervention_name>
    <arm_group_label>OR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular Aneurysm Repair</intervention_name>
    <arm_group_label>EVAR</arm_group_label>
    <other_name>Excluder, Talent, Zenith, AneuRx</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asymptomatic, infrarenal AAA that requires surgery

          -  Adequate infrarenal neck

          -  Other aortic-iliac anatomical configuration suitable for EVAR according to the
             criteria of the device to be used

          -  Patient having a life expectation of at least 2 years and cleared for transabdominal
             intervention

          -  Signed informed consent

        Exclusion Criteria:

          -  ruptured AAA or symptomatic AAA, which requires emergency surgery

          -  maximum aneurysm diameter&lt; 5.0 cm

          -  suprarenal AAA

          -  Inflammatory AAA (more than minimal wall thickening)

          -  infrarenal neck unsuitable for endovascular fixation or aortic-iliac anatomic
             configuration otherwise unsuitable for EVAR according to criteria of the device to be
             used

          -  bilateral retroperitoneal incision required for EVAR

          -  sacrifice of both hypogastric arteries required

          -  anatomical variations, i.e. horseshoe-kidney, arteries requiring reimplantation

          -  patient unsuitable for laparotomy

          -  administration of contrast agent not possible: proved, severe systemic reaction to
             contrast agent

          -  active infection present

          -  transplantation-patients

          -  limited life expectation due to other illness (&lt; 2 year)

          -  non-iatrogenic bleeding diathesis

          -  connective tissue disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J D Blankensteijn, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University Nijmegen Mecial Center, The Netherlands</affiliation>
  </overall_official>
  <results_reference>
    <citation>Prinssen M, Buskens E, Blankensteijn JD. The Dutch Randomised Endovascular Aneurysm Management (DREAM) trial. Background, design and methods. J Cardiovasc Surg (Torino). 2002 Jun;43(3):379-84.</citation>
    <PMID>12055570</PMID>
  </results_reference>
  <results_reference>
    <citation>Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR, Balm R, Buskens E, Grobbee DE, Blankensteijn JD; Dutch Randomized Endovascular Aneurysm Management (DREAM)Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004 Oct 14;351(16):1607-18.</citation>
    <PMID>15483279</PMID>
  </results_reference>
  <results_reference>
    <citation>Prinssen M, Buskens E, Blankensteijn JD; DREAM trial participants. Quality of life endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg. 2004 Feb;27(2):121-7.</citation>
    <PMID>14718892</PMID>
  </results_reference>
  <results_reference>
    <citation>Prinssen M, Buskens E, Nolthenius RP, van Sterkenburg SM, Teijink JA, Blankensteijn JD. Sexual dysfunction after conventional and endovascular AAA repair: results of the DREAM trial. J Endovasc Ther. 2004 Dec;11(6):613-20.</citation>
    <PMID>15615551</PMID>
  </results_reference>
  <results_reference>
    <citation>Blankensteijn JD, de Jong SE, Prinssen M, van der Ham AC, Buth J, van Sterkenburg SM, Verhagen HJ, Buskens E, Grobbee DE; Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005 Jun 9;352(23):2398-405.</citation>
    <PMID>15944424</PMID>
  </results_reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2007</study_first_posted>
  <last_update_submitted>June 3, 2008</last_update_submitted>
  <last_update_submitted_qc>June 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2008</last_update_posted>
  <keyword>Abdominal aortic aneurysm</keyword>
  <keyword>AAA</keyword>
  <keyword>randomised controlled trial</keyword>
  <keyword>Endovascular repair</keyword>
  <keyword>conventional open repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

